Filos Health Laboratory to Attend JPMorgan Healthcare Week 2026

DALLAS - Rezul -- Filos Health Laboratory and Filos Health Mobile Blood Collection, a CLIA- and COLA-accredited clinical diagnostics and mobile blood company specializing in precision laboratory testing and AI-powered clinical intelligence, announced today that it will attend JPMorgan Healthcare Week 2026 in San Francisco.

During JPM Health Week, Filos Health will engage with healthcare investors, health system leaders, biopharma partners, and innovators to discuss its mission to transform clinical diagnostics by moving beyond static lab results toward predictive, longitudinal insights that improve patient outcomes.

Filos Health integrates high-quality clinical laboratory testing with advanced artificial intelligence to analyze longitudinal lab data and predict clinical outcomes at 6-month and 12-month horizons. The company currently serves tens of thousands of patients annually across Texas and California, supporting physicians, health systems, and enterprise partners with scalable diagnostic and mobile phlebotomy solutions.

More on Rezul News

• A High-Velocity Growth Story Emerges in Marine and Luxury Markets
• $26 Billion Global Market by 2035 for Digital Assets Opens Major Potential for Currency Tech Company with ATM Expansion and Deployment Plans Underway
• Why OKC Homeowners Should Start the Year with Home Maintenance
• Peernovation 365 is Now Available
• SoilCertify - Professional Grade, 10M Resolution Soil Intelligence At A Fraction Of The Cost

"Healthcare generates vast amounts of laboratory data, yet most of it remains underutilized," said Nida Fatima, MD, Founder and CEO of Filos Health Laboratory. "At Filos Health, we believe lab data should not just report the past—it should help predict the future. JPM Healthcare Week provides an important forum to share how we are building the clinical operating system for human biology."

Filos Health is actively engaging with strategic partners and investors aligned with its vision to modernize clinical diagnostics, improve care delivery, and enable data-driven precision medicine at scale.

About Filos Health Laboratory
Filos Health Laboratory is a women-owned, CLIA- and COLA-accredited clinical diagnostics company delivering precision laboratory testing, mobile phlebotomy services, and AI-powered clinical intelligence. Founded in 2018, the company serves patients and providers across Texas and California, with a mission to turn laboratory data into actionable insights that improve health outcomes.

Learn more about clinical diagnostic company: https://www.filoshealthlab.ocm
Learn more about mobile blood collection: https://www.filoshealth.com